GB847713A - 19-nor-steroid compounds and process for the preparation thereof - Google Patents
19-nor-steroid compounds and process for the preparation thereofInfo
- Publication number
- GB847713A GB847713A GB12897/58A GB1289758A GB847713A GB 847713 A GB847713 A GB 847713A GB 12897/58 A GB12897/58 A GB 12897/58A GB 1289758 A GB1289758 A GB 1289758A GB 847713 A GB847713 A GB 847713A
- Authority
- GB
- United Kingdom
- Prior art keywords
- converted
- pregnene
- keto
- androstene
- dihydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
The invention comprises (1) 19-nor-steroids of the formulae: <FORM:0847713/IV(b)/1> wherein R1 is H(OH) or = O, R is hydrogen or a carboxylic acid acyl group containing at most 10 carbon atoms and Y is hydrogen, methyl, ethyl or vinyl; (2) 19-nor-steroids of the formula: <FORM:0847713/IV(b)/2> wherein R1 is hydrogen or OH and R is H, OH or acyloxy, the acyl group being derived from a carboxylic acid of at most 10 carbon atoms; (3) D 4-11b : 17a -dihydroxy-20-keto-19-nor-pregnene; and (4) a process for the preparation of 19-nor-steroids of the formula: <FORM:0847713/IV(b)/3> wherein R1 is H2, H(OH) or = O and R2 is (H) COCH3, (OH) COCH3, (H) COCH2OR3 (H) OR3 or (R4)OR3, R3 being hydrogen or an, acyl radial as defined above and R4 being methyl, ethyl or vinyl, comprising reacting a corresponding compound containing an acyloxy, alkyloxy, aryloxy or aralkyloxy group in the 3-position with an alkali metal in liquid ammonia or an aliphatic primary amine containing at most 6 carbon atoms, by which process the substituent in the 3-position is split off. The reaction is advantageously carried out at below 0 DEG C. in a solvent such as an ether. In examples (1) \se4-11b : 17b -dihydroxy-3-keto-17a -methyl-19-nor-androstene is reduced to the corresponding 3-o1, this is converted to the 3-methyl ether, this is reduced by the process of the invention to \se4 - 11b : 17b - dihydroxy - 17a - methyl-19-nor-androstene and this is converted into various 17-esters; (2) the corresponding 17a -vinyl compounds are prepared similarly via the 3-isopropyl ether, and \se4-3 : 11-diketo-17b -hydroxy-17a -ethyl-19-nor-androstene is similarly converted to \se4- 11 - keto - 17b - hydroxy - 17a -ethyl-19-nor-androstene and esters thereof; (3) \se4-21-hydroxy-3 : 20-diketo-19-nor-pregnene is reduced to \se4-3 : 20 : 21-trihydroxy-19-nor-pregnene, this is converted to the tripropionyloxy compound, this is reduced by the process of the invention to \se4-20 : 21-dipropionyloxy-19-nor-pregnene, this is saponified to the 20 : 21-diol, this is converted to the 21-acetate, this is oxidized to \se4-hydroxy-20-keto-19-nor-pregnene-21-acetate and this is saponified to the 21-o1 and converted to various others esters;(4) D 4-11b : 17a -dihydroxy-20-keto-19-nor-pregnene and \se4-17a : 21-dihydroxy-20-keto-19-nor-pregnene are prepared similarly, except that the oxidation is performed on the 21-o1 to form the second named compound which is subsequently converted to various esters; (5) \se4-3 : 20-diketo-19-nor-pregnene is similarly converted to \se4-20-keto-19-nor-pregnene via the 3 : 20-dihydroxy compound and the 3-methyl ether thereof, and \se4-17a -hydroxy-3 : 20 diketo-19-nor-pregnene is similarly converted to \se4-17a -hydroxy-20-keto-19-nor-pregnene via the 3-triphenylmethyl ether; (6) \se4-17a : 21-dihydroxy-3 : 11 : 20-triketo-19-nor-pregnene similarly gives a 3-methoxy-17a : 20b : 21-trihydroxy compound, this is treated by the process of the invention, the product is acetylated in the 21-position, the acetate is oxidized to \se4 - 17a : 21-dihydroxy-11 : 20-diketo-19-nor-pregnene-21-acetate which is either saponified and converted to various other esters or converted to the 20-mono-semicarbazone and then reduced and hydrolysed to give \se4-11b : 17a : 21-trihydroxy-20-keto-19-nor-pregnene-21-acetate which is subsequently hydrolysed to the 21-o1 and converted to various other esters; (7) \se4-17-hydroxy-3-keto-19-nor-androstene is converted to \se4-17b -hydroxy-19-nor-androstene via the 3 : 17-dihydroxy compound and the diacetate thereof; (8) \se4-3-keto-11b : 17b -dihydroxy-19-nor-androstene is reduced to the 3-o1, this is esterified to the 3 : 17b -dicyclopentylpropionate, this is reduced by the process of the invention and the product is saponified to give \se4 - 11b : 17b -dihydroxy-19-nor-androstene and this is either converted to various esters or oxidized to \se4-11 : 17-diketo-19-nor-androstene; and (9) \se4-17b -hydroxy-17a -methyl-3-keto-19-nor-androstene is converted via the 3-ethyl ether to \se4-17b -hydroxy-17a -methyl-19-nor-androstene and the corresponding 17a -ethyl compound is similarly prepared. In the general description the exemplified processes are referred to in more general terms and lists of etherifying and esterifying groups and reagents are provided. The protection of keto groups by ketalization is also referred to. Specifications 811,961 and 841,411 are referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL847713X | 1957-05-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB847713A true GB847713A (en) | 1960-09-14 |
Family
ID=19845229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB12897/58A Expired GB847713A (en) | 1957-05-01 | 1958-04-23 | 19-nor-steroid compounds and process for the preparation thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB847713A (en) |
-
1958
- 1958-04-23 GB GB12897/58A patent/GB847713A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB901293A (en) | Improvements in or relating to steroids | |
GB847713A (en) | 19-nor-steroid compounds and process for the preparation thereof | |
EP0072200A3 (en) | Steroidal esters and process for the preparation of steroidal esters | |
GB1472922A (en) | Pregnanoic acid derivatives | |
US2677695A (en) | Process for preparing 17alpha-hydroxy 20-keto steroids | |
US2800489A (en) | 11-trifluoroacetoxy steroids and process | |
Sarett | Preparation of pregnane-17α, 21-diol-3, 11, 20-trione acetate | |
US3023227A (en) | 5, 7-seco-b-norandrostane derivatives | |
US3056809A (en) | Method for introducing an oxygen function into a steroid molecule containing an enol group and compounds thereof | |
US3176032A (en) | 17alpha, 21-diacyloxy derivatives of 6alpha-methyl-delta1, 4-pregnadien-3, 20-dione and of 6alpha-methyl-delta4-pregnen-3, 20-dione | |
US2868783A (en) | 11-oxygenated-17alpha, 21-dihydroxy-4-pregnen-20-ones and the 21-esters thereof | |
US2752370A (en) | Process for producing delta16-20 keto steroids from 16-substituted-20-keto steroids | |
US3086033A (en) | 1-methyl-17-alkyl-11-oxygenated delta1, 3, 5 (10)-estrogenic compounds | |
US2740797A (en) | Steroids | |
US2773074A (en) | Process for the production of allopregnane-3beta, 11beta, 17alpha, 20beta, 21-pentols | |
US3081317A (en) | Process for preparing 1, 4-androstadiene-2, 17beta-diol-3-one | |
US2538731A (en) | Metal oxide treatment of 3-formoxy steroids | |
GB773926A (en) | Improvements relating to pregnane compounds | |
GB794392A (en) | Steroid compounds and the preparation thereof | |
US2835684A (en) | 14alpha hydroxy, 16 halo-pregnene compounds | |
US3072645A (en) | 17alpha:21-dihydroxy-20-ketones of the pregnane series and process for their manufacture | |
US3329693A (en) | delta1, 4-17alpha, 20beta, 21-trihydroxy-3, 11-diketopregnadiene-derivatives | |
US3072644A (en) | 20, 21-ketols of the pregnane series and process for their manufacture | |
US3274183A (en) | 3-(17beta-hydroxy-1, 4-dimethylestra-1, 3, 5(10)-trien-17alpha-yl) propionic acid lactone and intermediates | |
US3203965A (en) | 6alpha-methyl-delta1, 4-pregnadien-17alpha-ol-3, 20-dione and esters thereof |